-
LEO Pharma Presents Late-Breaking Results on Temtokibart for Atopic Dermatitis at EADV
18 Sep 2025 17:11 GMT
… Annual Meeting in Paris, France, LEO Pharma presented two late-breaking abstracts … advantages in specificity and safety. LEO Pharma has obtained a worldwide exclusive … , Science, Search & Innovation at LEO Pharma.
References
1. Weidinger S, et …
-
<![CDATA[EADV 2025 Congress Recap: 14 Late-Breaking Trials to Know]]>
21 Sep 2025 22:47 GMT
… -22RA1–targeting monoclonal antibody from LEO Pharma, improved disease severity and biomarker …
-
<![CDATA[ECZTEND: Tralokinumab Use Leads to Stable Long-Term Effects in Atopic Dermatitis]]>
20 Sep 2025 22:30 GMT
… on tralokinumab were announced by LEO Pharma and presented at the 2025 …
-
<![CDATA[Discussing Phase 2b Findings on Temtokibart for Atopic Dermatitis, With Chih-ho Hong, MD, FRCPC]]>
20 Sep 2025 17:42 GMT
… data were announced by LEO Pharma and presented at the … , and Valeant.
References
Leo Pharma. LEO Pharma presents two late-breaking abstracts … Annual Meeting in Paris. Leo-pharma.com. Published September 17, … https://www.leo-pharma.com/media-center…
-
<![CDATA[Understanding Temtokibart's Potential in Atopic Dermatitis, With Stephan Weidinger, MD, PhD]]>
20 Sep 2025 17:42 GMT
… include AbbVie, Almirall, Galderma, Kymab, LEO Pharma, Eli Lilly and Company, Pfizer … Roche Posay, and Sanofi.
References:
Leo Pharma. LEO Pharma presents two late-breaking abstracts … EADV Annual Meeting in Paris. Leo-pharma.com. Published September 17, 2025 …
-
<![CDATA[Long-Term Treatment with Ritlecitinib for Alopecia Areata, With Brett King, MD, PhD]]>
20 Sep 2025 17:42 GMT
… and Company, Incyte, Janssen Pharmaceuticals, LEO Pharma, Merck, Otsuka/Visterra, Pfizer …
-
Baricitinib Response Deepens Over Time in Alopecia Areata, With Brett King, MD, PhD
20 Sep 2025 12:47 GMT
… and Company, Incyte, Janssen Pharmaceuticals, LEO Pharma, Merck, Otsuka/Visterra, Pfizer …
-
<![CDATA[Significance of Cardiovascular Data on Upadacitinib for Atopic Dermatitis, With Christopher Bunick, MD, PhD]]>
20 Sep 2025 12:30 GMT
… an investigator for AbbVie, Incyte, LEO Pharma and Pfizer.
References
Bunick C …
-
FDA approves Opzelura cream for pediatric atopic dermatitis
20 Sep 2025 00:34 GMT
… , Galderma, Incyte, Johnson & Johnson, Leo Pharma, Eli Lilly, Pfizer, Primus Pharmaceuticals … , KP Away, L’Oreal, LearnSkin, LEO Pharma, Level Ex, Menlo Therapeutics, Micreos …
-
DELTA TEEN Trial Demonstrates Superiority of Delgocitinib Cream in Adolescents With Chronic Hand Eczema
19 Sep 2025 18:21 GMT
… science, search, and innovation at LEO Pharma, in the news release. … 16 weeks.2
References
LEO Pharma presents late-breaking phase … ;20250918307792/en/LEO-Pharma-Presents-Late-Breaking-Phase-3 … ) in adults. News release. LEO Pharma Inc. July 23, 2025. …
About
© 1995-2025